Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6114220 | Transfusion and Apheresis Science | 2013 | 7 Pages |
Abstract
Our results indicate that Canadian FP is of similar quality to single-donor products produced in other jurisdictions. While it is of arguably superior in vitro quality to an SD plasma product recently licensed in Canada, these differences are highly unlikely to have clinical significance for most indications for plasma transfusion.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
William P. Sheffield, Varsha Bhakta, Kimberley Talbot, Edward L.G. Pryzdial, Craig Jenkins,